Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

24.20USD
2:11pm EDT
Price Change (% chg)

$-0.87 (-3.47%)
Prev Close
$25.07
Open
$24.89
Day's High
$25.13
Day's Low
$23.37
Volume
13,254
Avg. Vol
41,570
52-wk High
$26.97
52-wk Low
$10.40

STML.OQ

Chart for STML.OQ

About

Stemline Therapeutics, Inc. (Stemline) is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target both cancer stem cells (CSCs) and tumor bulk. The Company is developing two clinical-stage product candidates, SL-401 and SL-701, for which it holds... (more)

Overall

Beta: --
Market Cap (Mil.): $311.72
Shares Outstanding (Mil.): 12.43
Dividend: --
Yield (%): --

Financials

  STML.OQ Industry Sector
P/E (TTM): -- 34.45 32.18
EPS (TTM): -2.38 -- --
ROI: -64.51 -2.81 18.91
ROE: -70.04 -3.51 19.87
Search Stocks

Competitors

  Price Change
Astellas Pharma Inc (4503.T) ¥5,490 +60.00
Eisai Co., Ltd (4523.T) ¥4,095 +10.00
Dainippon Sumitomo Pharma Co., Ltd. (4506.T) ¥1,354 +25.00
Pfizer Inc. (PFE.N) $27.69 -0.09
Novartis AG (NOVN.VX) CHF67.45 +0.15
Merck & Co., Inc. (MRK.N) $46.36 +0.04
Roche Holding Ltd. (ROG.VX) CHF235.70 +1.10
Sanofi SA (SASY.PA) €78.82 -1.05
GlaxoSmithKline plc (GSK.L) 1,670.00p +11.50
Amgen, Inc. (AMGN.OQ) $96.02 -1.47

Earnings vs. Estimates

Search Stocks